西德《慕尼黑医学周刊》第122卷第4期第416页(1980年)报道:为了证实免疫抑制疗法能促进恶性肿瘤发生的说法,由英国、澳大利亚、新西兰研究人员组成的研究小组观察了服用硫唑嘌呤或苯丁酸氮芥(瘤可宁)至少3个月患者的癌发生率。据报道,3,823名肾移植后接受免疫抑制剂的患者,他们中非何杰金氏淋巴瘤、皮肤癌和间质瘤的发病率几乎比预料的高60倍。另外又观察了1,349名由于其他 West Germany’s Munich Medical Journal, Vol. 122, No. 4, page 416 (1980) reports: In order to substantiate the claim that immunosuppressive therapy promotes malignancy, a team of researchers from the United Kingdom, Australia, and New Zealand observed the use of The incidence of cancer in azathioprine or chlorambucil (cancer) for at least 3 months. According to reports, 3,823 patients who received immunosuppressive agents after kidney transplantation had an incidence of non-Hodgkin’s lymphoma, skin cancer, and stromal tumor that was almost 60 times higher than expected. Also observed 1,349 other due to other